EGFR-targeted photoimmunotherapy and its association with the immune microenvironment in locoregional recurrent head and neck squamous cell carcinoma

BackgroundEpidermal growth factor receptor (EGFR)-targeted photoimmunotherapy using cetuximab sarotalocan sodium (RM-1929) represents a novel therapeutic modality that induces selective tumor cell death and may influence the tumor immune microenvironment (TIME) in head and neck squamous cell carcino...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Koichi Yoshizawa, Takahiro Tsujikawa, Peesit Leelasawatsuk, Mai Mohamed Bedeir, Yuna van der Aar, Tim de Martines, Saya Shibata, Hiroshi Ogi, Ryuhei Okada, Alisa Kimura, Hiroki Morimoto, Sumiyo Saburi, Shigeyuki Mukudai, Hikaru Nagao, Aya Miyagawa-Hayashino, Eiichi Konishi, Kyoko Itoh, Takahiro Asakage, Shigeru Hirano
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-04-01
Serie:	Frontiers in Immunology
Soggetti:	EGFR head and neck squamous cell carcinoma immune microenvironment locoregional recurrence photoimmunotherapy
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1814205/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!